Higher Dose Wegovy Approved for Obesity Treatment
Dover News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Federal regulators have approved a higher dose of the obesity drug Wegovy, aiming to help more people lose weight. The new version, with seven point two milligrams of semaglutide per weekly shot, is set to hit U.S. pharmacies in April. This approval came through the FDAs fast-track review program, and it could be a game-changer for those not seeing results on the standard dose. However, experts will closely monitor real-world side effects as more patients try this stronger option.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/937b4bf92b0700fd